NCT02570672View on ClinicalTrials.gov

Metformin for Preventing Frailty in High-risk Older Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 7, 2024

Study Completion Date

February 7, 2024

Conditions
Frailty
Interventions
DRUG

Metformin

Subjects will be randomized to metformin titrated to 1000mg twice daily as tolerated.

DRUG

Placebo

Subjects will randomized to placebo will receive placebo

Trial Locations (1)

78229

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT02570672 - Metformin for Preventing Frailty in High-risk Older Adults | Biotech Hunter | Biotech Hunter